Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapteijn, B. A.
Right arrow Articles by Kroon, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapteijn, B. A.
Right arrow Articles by Kroon, B. B.

Annals of Surgical Oncology, Vol 4, Issue 2 156-160, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye

B. A. Kapteijn, O. E. Nieweg, I. Liem, W. J. Mooi, A. J. Balm, S. H. Muller, J. L. Peterse, R. A. Valdes Olmos, C. A. Hoefnagel and B. B. Kroon
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands.

BACKGROUND: Sentinel node (SN) biopsy can be used to select patients with melanoma for therapeutic lymphadenectomy. We investigated the value of two methods to locate the SN: patent blue dye (PBD) and gamma probe detection of 99mTc-nanocolloid. METHODS: One hundred ten patients with cutaneous melanoma were studied. Lymphoscintigraphy with 99mTc-nanocolloid was performed to determine the position of the SN. Before operation, PBD was injected at the same site as the radiopharmaceutical. When a blue node was identified intraoperatively, its radioactivity level was measured with the probe. In the absence of blue coloration, the probe was used to trace the SN. RESULTS: Scintigrams visualized a total of 219 SNs in 141 basins. Eight SNs were not explored. One SN was not found. The remaining 210 and 27 additional intraoperatively identified SNs were excised. From the total of 237 removed SNs, 200 (84%) were found using PBD only. All 37 nodes that were not found with the PBD were localized with the probe so that the probe combined with PBD identified 99.5% of all SNs. In 23 patients the SN contained tumor. In three patients the SN was false-negative for metastasis. CONCLUSION: The gamma probe together with PBD can identify more SNs (99.5%) than lymphatic mapping with PBD alone (84%).


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
S.-H. Choi, Y. Kono, J. Corbeil, O. Lucidarme, and R. F. Mattrey
Model to Quantify Lymph Node Enhancement on Indirect Sonographic Lymphography
Am. J. Roentgenol., August 1, 2004; 183(2): 513 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. M. Pawlik, M. I. Ross, and J. E. Gershenwald
Lymphatic Mapping in the Molecular Era
Ann. Surg. Oncol., April 1, 2004; 11(4): 362 - 374.
[Full Text] [PDF]

Home page
 JNMHome page
G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al.
Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma*
J. Nucl. Med., June 1, 2002; 43(6): 811 - 827.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P.J. Tanis, O.E. Nieweg, A.A. M. Hart, and B.B. R. Kroon
The Illusion of the Learning Phase for Lymphatic Mapping
Ann. Surg. Oncol., March 1, 2002; 9(2): 142 - 147.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. S. Krouse, R. E. Schwarz, and S. P. L. Leong
Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive?
Ann. Surg. Oncol., April 1, 2001; 8(3): 268 - 269.
[Full Text] [PDF]

Home page
 JCOHome page
J. A. de Hullu, H. Hollema, D. A. Piers, R. H. M. Verheijen, P. J. van Diest, M. J. E. Mourits, J. G. Aalders, and A. G. J. van der Zee
Sentinel Lymph Node Procedure Is Highly Accurate in Squamous Cell Carcinoma of the Vulva
J. Clin. Oncol., August 15, 2000; 18(15): 2811 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
G. W. Carlson, D. R. Murray, R. Greenlee, N. Alazraki, C. Fry-Spray, R. Poole, M. Blais, A. Hestley, and J. Vansant
Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscintigraphy and Gamma Probe-Guided Sentinel Lymph Node Biopsy
Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 433 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
S. P. L. Leong, T. A. Achtem, F. A. Habib, I. Steinmetz, E. Morita, R. E. Allen, M. Kashani-Sabet, and R. Sagebiel
Discordancy Between Clinical Predictions vs Lymphoscintigraphic and Intraoperative Mapping of Sentinel Lymph Node Drainage of Primary Melanoma
Arch Dermatol, December 1, 1999; 135(12): 1472 - 1476.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K. M. McMasters, A. E. Giuliano, M. I. Ross, D. S. Reintgen, K. K. Hunt, D. R. Byrd, V. S. Klimberg, P. W. Whitworth, L. C. Tafra, and M. J. Edwards
Sentinel-Lymph-Node Biopsy for Breast Cancer -- Not Yet the Standard of Care
N. Engl. J. Med., October 1, 1998; 339(14): 990 - 995.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society of Surgical Oncology.